Recombinant Human Chromodomain-helicase-DNA-binding protein 2 protein (1569-1828AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Isotype
IgG
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Tested Applications
ELISA, IHC
Recommended Dilution
Application
Recommended Dilution
IHC
1:20-1:200
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
Usage
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
DNA-binding helicase that specifically binds to the promoter of target genes, leading to chromatin remodeling, possibly by promoting deposition of histone H3.3. Involved in myogenesis via interaction with MYOD1: binds to myogenic gene regulatory sequences and mediates incorporation of histone H3.3 prior to the onset of myogenic gene expression, promoting their expression.
Gene References into Functions
Germline mosaicism resulted in a CHD2 gene missense variant and the development of autism spectrum disorder in two siblings.PMID:28960266
study reports monozygotic twins with a global neurodevelopmental delay associated with an autism spectrum disorder, hypotonia, postnatal microcephaly, stereotypic movements and circadian rhythm alterations in association with late-onset epilepsy; identified a CHD2 mutation, previously described in association with a phenotypic spectrum overlapping our patients' phenotypePMID:26754451
Results indicate a PARP1-dependent mechanism that regulates non-homologous end-joining through localized chromatin expansion and deposition of the histone variant H3.3 by CHD2 at DNA breaks promoting DNA repair.PMID:26895424
CHD2 mutations are responsible in rare cases for generalized epilepsy with myoclonic-atonic seizures.PMID:26262932
CHD2 is a cancer driver and has a role as chromatin remodeler in chronic lymphocytic leukemia.PMID:26031915
CHD2 mutation is the first identified cause of the archetypal generalized photosensitive epilepsy syndromePMID:25783594
The phenotypic spectrum of CHD2 encephalopathy has distinctive features of myoclonic epilepsy with marked photosensitivity.PMID:25672921
Human CHD2 is a chromatin assembly ATPase regulated by its chromatin- and DNA-binding domains.PMID:25384982
Our findings suggest that CHD2 mutations are important in the etiological spectrum of Lennox-Gastaut syndrome.PMID:24614520
De novo loss-of-function mutations in CHD2 are a cause of epileptic encephalopathy with generalized seizures.PMID:24207121
De novo CHD2 and SYNGAP1 mutations are new causes of epileptic encephalopathies, accounting for 1.2% and 1% of cases, respectively.PMID:23708187
detected a homozygous deletion of chromosomal region 15q26.2 in the cell line HDLM2 encompasing RGMA and CHD2PMID:17606441